With Massachusetts-based Dragonfly BMS is taking a different tack and focusing on DF6002, a long-lasting fusion protein that looks like the “tail” (Fc) end of an IL-12 antibody. The companies ...

Antibodies are both blockbuster biopharmaceuticals and some of the most versatile reagents in the laboratory toolkit. But many antibody lines are not consistent or do not work as described ...

Tonix Pharmaceuticals has reported positive topline outcomes from its Phase I single ascending dose study of its crystallisable fragment (Fc)-modified ... monoclonal antibody, TNX-1500, in healthy ...

Proteintech has designed recombinant antibodies featuring the company's FcZero backbone, engineered to silence the Fc domain ...

In addition to enhancing the pharmacological properties of monoclonal antibodies, a detailed understanding of the function of their Fc receptors in health and disease has important implications ...

Agenus has robust end-to-end development capabilities ... About Botensilimab (BOT) Botensilimab (BOT) is a human Fc enhanced CTLA-4 blocking antibody designed to boost both innate and adaptive ...